Feasibility, Safety and Efficacy of the Combination of D-Serine and Computerized Cognitive Retraining in Schizophrenia: An International Collaborative Pilot Study

Glycine Transporter Inhibitor Attenuates the Psychotomimetic Effects of Ketamine in Healthy Males: Preliminary Evidence

(2011) Deepak Cyril D'Souza et al.   NEUROPSYCHOPHARMACOLOGY

Thinking About the Future Cognitive Remediation Therapy--What Works and Could We Do Better?

(2011) T. Wykes et al.   SCHIZOPHRENIA BULLETIN

Negative Symptoms of Schizophrenia as Primary Target of Cognitive Behavioral Therapy: Results of the Randomized Clinical TONES Study

(2011) S. Klingberg et al.   SCHIZOPHRENIA BULLETIN

Three Year Follow-Up Study of an Integrated Supported Employment for Individuals with Severe Mental Illness

(2010) Hector W.H. Tsang et al.   AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY

Group 5 metabotropic glutamate receptors: Role in modulating cortical activity and relevance to cognition

(2010) Houman Homayoun et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Discovery of 4-(5-Methyloxazolo[4,5-b]pyridin-2-yl)-1,4-diazabicyclo[3.2.2]nonane (CP-810,123), a Novel α7 Nicotinic Acetylcholine Receptor Agonist for the Treatment of Cognitive Disorders in Schizophrenia: Synthesis, SAR Development, and in Vivo Efficacy in Cognition Models

(2010) Christopher J. O’Donnell et al.   JOURNAL OF MEDICINAL CHEMISTRY

Cognitive remediation therapy needs funding

(2010) Til Wykes   NATURE

Report From the Working Group Conference on Multisite Trial Design for Cognitive Remediation in Schizophrenia

(2010) R. S. E. Keefe et al.   SCHIZOPHRENIA BULLETIN

High dose D-serine in the treatment of schizophrenia

(2010) Joshua T. Kantrowitz et al.   SCHIZOPHRENIA RESEARCH

A randomized, controlled trial of computer-assisted cognitive remediation for schizophrenia

(2010) Thierry d'Amato et al.   SCHIZOPHRENIA RESEARCH

Treating the Cognitive Deficits of Schizophrenia with Alpha4Beta2 Neuronal Nicotinic Receptor Agonists

(2009) Richard Radek et al.   CURRENT PHARMACEUTICAL DESIGN

Activity-dependent synaptic plasticity of NMDA receptors

(2009) Nelson Rebola et al.   JOURNAL OF PHYSIOLOGY-LONDON

AC-260584, an orally bioavailable M1 muscarinic receptor allosteric agonist, improves cognitive performance in an animal model

(2009) Stefania Risso Bradley et al.   NEUROPHARMACOLOGY

Lamotrigine inhibits postsynaptic AMPA receptor and glutamate release in the dentate gyrus

(2008) Chun-Yao Lee et al.   EPILEPSIA

Attention training in schizophrenia: Differing responses to similar tasks

(2008) Morris D. Bell et al.   JOURNAL OF PSYCHIATRIC RESEARCH

A Randomized Controlled Trial of Cognitive Remediation in Schizophrenia

(2008) M. A. R. Hodge et al.   SCHIZOPHRENIA BULLETIN

Attention Shaping: a Reward-Based Learning Method to Enhance Skills Training Outcomes in Schizophrenia

(2008) S. M. Silverstein et al.   SCHIZOPHRENIA BULLETIN

Predictors of change in life skills in schizophrenia after cognitive remediation

(2008) Matthew M. Kurtz et al.   SCHIZOPHRENIA RESEARCH

Differential effect of carbamazepine and oxcarbazepine on excitatory synaptic transmission in rat hippocampus

(2008) Michela Giustizieri et al.   SYNAPSE